Global Whole Exome Sequencing Market: Key Highlights
Global Whole Exome Sequencing Market: Key Market Dynamics
Request Sample PDF of Global Whole Exome Sequencing Market:
Global Whole Exome Sequencing Market: Regional Overview
North America is expected to witness remarkable growth owing to favorable support from the government to promote next-generation sequencing. In 2019, the National Institute of Health approved a funding of USD 7 million for one year dedicated for DNA sequencing technologies in order to improve disease diagnosis and treatment. In addition to this, growing prevalence of cancer in the region, is promoting the demand for next-generation DNA sequencing methods for rapid and accurate cancer diagnosis.
In Europe, the whole exome sequencing market is growing on the grounds of rise in adoption of genomic sequencing for precision medicine. Rising count of geriatric population, increasing prevalence of chronic medical conditions including genetic diseases and cancer, is driving the market growth. In 2018, approximately 3.91 million new cancer cases were diagnosed in Europe accounting for 1.93 million deaths from the disease, as stated by European Network of Cancer Registries (ENCR) and the European Commission's Joint Research Centre (JRC)
Global Whole Exome Sequencing Market: Key Players Overview
Illumina Inc. is a biotechnology company that operates globally through designing, manufacturing and commercialization of products and solutions in genetic research. The company offers a range of products such as sequencing instruments, microarray scanners, library preparation kits, sequencing reagents, microarray kits and software and services for genetic research. In May 2017, the company signed an agreement with Integrated DNA Technologies, Inc. to offer library preparation multiplexing and target enrichment solutions. The agreement includes co-marketing of complete workflow for exome capture through coupling of Illumina’s TruSeq & Nextera library prep kits with IDT’s xGen Exome Research Panel.
PerkinElmer, Inc. is engaged in providing technology, services, and solution globally. The company manufactures and markets consumables, accessories, informatics, reagents., instruments, software mostly for diagnostics, microbial analysis, and life science research. It provides Whole Exome Sequencing (WES) tests with better coverage of region with disease causing genes. In April 2018, PerkinElmer, Inc. partnered with personal genomics company, Helix for development and marketing of whole exome sequencing-based tests to promote better health management decision.
About Forencis Research
Forencis Research is a B2B market research, intelligence and advisory firm engaging in market research and consulting services across leading industries, globally. Our robust and meticulous research team provides high growth and niche syndicated reports, customized reports and consulting reports to the diverse global fortune clientele and intellectual institutions. Forencis Research database is a constantly evolving pool of market research reports and white paper studies which helps companies to foster accelerated revenue growth in global and regional markets.
Our robust research methodology is designed to constantly map the high growth markets in various industries. This facilitates enhanced decision-making capabilities to our clients. Our robust research methodology is designed to constantly map the high growth markets in various industries. This facilitates enhanced decision-making capabilities to our clients. We strive to help our clients to foray into uncharted space to attain increased revenue growth for the present as well as the future.
Phone: +1 (720) 306 9020